TYP 5.00% 2.1¢ tryptamine therapeutics limited

Ann: Exopharm LEAP Technology - Second Commercial Collaboration, page-7

  1. 16,819 Posts.
    lightbulb Created with Sketch. 356
    I don't think anyone has been able to travel to Japan and vice versa so this is a promising development. There'll be many more.

    No matter how good your product or technology is it takes time to establish relationships and prove up your worth.

    This company is doing everything right.

    Once it becomes easier for execs. to travel opportunities will turn into outcomes.
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.